Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, drugstore and pharmacy benefits giant CVS Caremark (NYSE: CVS) has earned a respected four-star ranking.

With that in mind, let's take a closer look at CVS Caremark's business and see what CAPS investors are saying about the stock right now.

CVS facts

Headquarters (Founded) Woonsocket, R.I. (1892)
Market Cap $56.0 billion
Industry Drug retail
Trailing-12-Month Revenue $104.0 billion
Management CEO Larry Merlo (since 2011)
CFO David Denton (since 2010)
Return on Equity (Average, Past 3 Years) 9.7%
Cash/Debt $1.7 billion / $10.8 billion
Dividend Yield 1.5%
Competitors Rite Aid

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 96% of the 1,688 members who have rated CVS believe the stock will outperform the S&P 500 going forward.  

Last year, one of those bulls, DeeFool33, tapped CVS as a particularly clear opportunity:

I'm a fan of Peter Lynch's "buy what you know" and I am IN these stores all the time. CVS is always busy -- and I mean always at the many locations I frequent in [Massachusetts]. Rite-Aid, well, I rarely see more than 6 cars in the parking lot, ever. CVS is targeting its customer base with coupons, incentives all the time. They are always trying to attract business. Walgreens -- not sure where that it heading -- seems middle of the road to me right now.

If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite a strong four-star rating, CVS may not be your top choice.

We've found another retailer we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2012." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.